Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus

This publication has 15 references indexed in Scilit:

• Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response
  AIDS, 2003
• Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults
  Journal of Virology, 2002
• Effect of Prolonged Discontinuation of Successful Antiretroviral Therapy on CD4⁺T Cell Decline in Human Immunodeficiency Virus–Infected Patients: Implications for Intermittent Therapeutic Strategies
  The Journal of Infectious Diseases, 2002
• Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy
  Antimicrobial Agents and Chemotherapy, 2002
• A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy
  AIDS, 2002
• Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia
  New England Journal of Medicine, 2001
• Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens
  AIDS, 2000
• Selected Topics from the Seventh Conference on Retroviruses and Opportunistic Infections, January 30 - February 2, 2000
  HIV Research & Clinical Practice, 2000
• Sustained CD4⁺T Cell Response after Virologic Failure of Protease Inhibitor–Based Regimens in Patients with Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2000
• Experience with a cross-study endpoint review committee for AIDS clinical trials
  AIDS, 1998